AIM IMMUNOTECH INC. Gain (Loss) on Disposition of Assets
AIM IMMUNOTECH INC. (AIM) reported Gain (Loss) on Disposition of Assets of $18.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2025-03-27
- AIM IMMUNOTECH INC. gain (loss) on disposition of assets for the quarter ending 2021-12-31 was $0.00.
- AIM IMMUNOTECH INC. gain (loss) on disposition of assets for the quarter ending 2021-09-30 was $0.00.
- AIM IMMUNOTECH INC. gain (loss) on disposition of assets for the quarter ending 2021-06-30 was $216.00K.
- AIM IMMUNOTECH INC. gain (loss) on disposition of assets for the quarter ending 2018-12-31 was $0.00.
- AIM IMMUNOTECH INC. gain (loss) on disposition of assets for fiscal 2023 was $18.00K.
- AIM IMMUNOTECH INC. gain (loss) on disposition of assets for fiscal 2021 was $216.00K.
- AIM IMMUNOTECH INC. gain (loss) on disposition of assets for fiscal 2018 was $223.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2023-12-31 | $18.00K 10-K · filed 2025-03-27 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $216.00K derived: sum of 3 quarters · filed 2023-03-31 | $216.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $216.00K derived: sum of 2 quarters · filed 2022-11-14 | $216.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $216.00K 10-Q · filed 2022-08-15 | $216.00K 10-Q · filed 2022-08-15 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | $0.00 derived: sum of 3 quarters · filed 2020-03-30 | $223.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $223.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $223.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $223.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |